In many conversations with founders, one of the first things I hear sounds something like this:

“Companies like mine are selling at 10x EBITDA.”
“A competitor sold three years ago at 12x, so my company should be worth at least that.”

Looking at comparable transactions, analysing recent deals in the same sector, or checking the multiples at which similar listed companies trade makes perfect sense. It is a reasonable way to get an initial feel for where the market is.

What should be avoided is turning that reference into an absolute truth.

Because multiples work as a rule of thumb: they help orient you, but they do not replace real analysis. Every company, at a specific moment in time and in front of a specific buyer, ends up with a price that can be very different from the market average.

Behind a “10x EBITDA” there is far more than meets the eye.

In the following sections, I explain why EBITDA is used as a reference, what market multiples actually tell us, why they vary so much by sector and geography, and—above all—why no serious buyer values a company based on a multiple alone.


Why EBITDA Became the Standard Reference

EBITDA is not a perfect metric, but it is the most practical one in M&A processes.

It is widely used because it allows buyers and sellers to:

  • Compare companies with different capital structures
  • Neutralise tax differences across countries
  • Reduce the impact of accounting policies
  • Approximate the operating profitability of the business
  • Serve as a basis to analyse cash conversion and leverage

In short, EBITDA is not ideal—but it is the common language spoken by buyers, banks, funds, and advisors.


What EBITDA Is and How It Is Calculated

EBITDA stands for:

Earnings Before Interest, Taxes, Depreciation and Amortization

In practice, it represents the company’s result before:

  • Interest
  • Taxes
  • Depreciation and amortisation

Two Common Ways to Calculate EBITDA

1. From the top of the income statement

The most intuitive approach:

  • Revenue
  • Operating costs (direct and indirect)
    = EBITDA

This view helps understand EBITDA as the pure result of operating activity.

2. From net income (bottom-up)

In many M&A processes, EBITDA is rebuilt starting from net profit:

  • Net income
  • Financial expenses
  • Taxes
  • Depreciation and amortisation
    = EBITDA

EBITDA Adjustments in M&A

In many transactions, EBITDA is adjusted to reflect the recurring earning capacity of the business. The goal is to remove items that do not represent normal operations, such as:

Non-recurring costs

One-off expenses linked to specific decisions, such as a particular restructuring or the shutdown of a business line.

Extraordinary expenses

Exceptional items that do not reflect normal operations, such as legal fees from a closed litigation, transaction-related costs (legal or M&A advisors), one-off penalties, or non-recurring fines.

Costs that will not continue after the transaction

Expenses linked to the current shareholder or management structure that will disappear post-transaction, such as the remuneration of a founder leaving the company, personal expenses charged to the business (still common in many SMEs), or board structures that will not be maintained.

Two important clarifications

First: EBITDA is not cash flow
A high EBITDA does not guarantee cash generation if CapEx, working capital consumption, or debt levels are high.

Second: poorly adjusted EBITDA destroys trust
When buyers see EBITDA inflated with aggressive adjustments or questionable “normalisations,” they interpret it as a lack of seriousness and immediately increase their perception of risk.


What an EBITDA Multiple Really Measures

A multiple does not measure the past.
It measures future expectations.

Buyers pay higher EBITDA multiples when they believe that EBITDA:

  • Will grow
  • Will convert well into cash
  • Is recurring and stable
  • Has low operational risk
  • Can scale without excessive capital requirements

This is why two companies with the same EBITDA can have radically different valuations.


Market Data: What Is the “Average” EBITDA Multiple?

According to PitchBook data (global median, 2025):

  • Global average: ~9x EBITDA
  • United States: ~9.5x
  • Europe: ~8.9x

Why EBITDA Multiples Are Higher in the U.S. Than in Europe

Higher U.S. multiples largely reflect the scale and opportunity of the market. When a company can grow for years within a single, large, homogeneous, and deep domestic market, expected growth is higher—and that is reflected in the multiple.

The comparison becomes very clear when looking at market size:

  • California: ~$4.1T GDP vs France: ~$3.2T
  • Texas: ~$2.7T vs Italy: ~$2.3T
  • New York: ~$2.3T vs Spain: ~$1.7T
  • Florida: ~$1.7T vs Poland: ~$0.9T

In markets like these:

  • Growth is more straightforward
  • The market is more homogeneous
  • Scalability is higher

The result is higher expected growth, less friction, and greater long-term visibility—leading to higher EBITDA multiples.


Historical Evolution of EBITDA Multiples

Looking at global average EBITDA multiples:

  • 2015–2019: stable environment (~9–9.7x)
  • 2021: exceptional peak (~10.7x)
  • 2022–2024: normalisation (~8.6–9x)

The message is clear: 2021 was the exception, not the rule.


Multiples by Sector: Not All EBITDA Is Worth the Same

Global median by sector (PitchBook)

EBITDA multiples

  • Technology: ~12–13x
  • Healthcare: ~11–12x
  • Financials: ~9–10x
  • B2C: ~8–9x
  • B2B: ~7–8x
  • Energy: ~6–7x
  • Materials & resources: ~8–9x

Revenue multiples

  • Financials: ~3.5x
  • Healthcare: ~2.5–2.7x
  • Technology: ~2.3–2.5x
  • B2B / B2C: ~1.1–1.2x

When both multiples are combined, the implicit EBITDA margin the market is paying becomes clear.

This explains why:

  • Tech is valued more for growth than for margins
  • Healthcare combines margin, stability, and visibility
  • Energy is penalised by volatility and CapEx
  • B2B and B2C have lower scalability

“My Company Is Worth 9x EBITDA or 1.5x Revenue”

A typical example:

  • €10M in revenue → 1.5x → €15M
  • €1M in EBITDA → 9x → €9M

So is it worth €15M or €9M?

The real answer is: it depends on the rest of the business.

The multiple is a reference.
The real valuation emerges from the full context.


What Buyers Look at Beyond EBITDA

Beyond EBITDA, buyers analyse a wide range of KPIs, including:

Revenue and growth

  • Historical and recent growth
  • Quality of growth (organic vs artificial)

Profitability

  • Gross margin
  • Margin stability
  • Quality of EBITDA

Cash

  • Operating cash flow
  • EBITDA-to-cash conversion
  • Liquidity runway

Customers

  • CAC and its evolution
  • LTV and underlying assumptions
  • LTV/CAC ratio
  • Churn
  • Net revenue retention (NRR)
  • Share of recurring revenue
  • Average revenue per customer

Sales

  • Conversion rates
  • Sales cycle length
  • Dependence on one-off sales

Balance sheet

  • Working capital
  • Collection and payment terms
  • Impact on cash needs

EBITDA summarises the business—but it does not explain it.


Three Final Reminders

1. Averages are not your reality
Market averages do not reflect your specific situation.

2. Size matters
Many datasets are driven by large deals. In mid-market and small-cap transactions, multiples are usually lower.

3. Price is not valuation
The final price depends on the fit with the right buyer, at the right moment.

EBITDA multiples are a useful tool.
But they are just that: a tool.

Real valuation appears when you:

  • Understand your metrics
  • Know how buyers interpret them
  • Build a credible financial story around them

By Joshua Novick, partner at Bondo Advisors

Source: https://www.joshuanovick.com/p/multiplos-de-ebitda-en-m-and-a-que

Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

19th Edition of the Spain Private Equity...

by SpainCap

Axon Partners Group, Tresmares Capital, Sabadell Venture Capital, Inve...

Photos Stream